Recruiting

SUPPORT-T vs. Enhanced Usual Care

Sponsor:

Medical University of South Carolina

Code:

NCT07269262

Conditions

Progressive Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SUPPORT-T Educational Intervention

Study Details

Brief summary:

This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.

Conditions

Progressive Pulmonary Fibrosis

Interstitial Lung Disease

Study ID

NCT07269262

Start date

Jan 13, 2026

Status verified date

Aug, 2025

Completion date

Oct 1, 2027

Anticipated

Primary completion date

Sep 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adults ≥18 years
  • Confirmed diagnosis of PPF
  • English or Spanish speaking

Caregiver Inclusion Criteria:

  • adult, ≥ 18 years old
  • Designated and identified by patient as providing most of the emotional, financial, and/or physical support (i.e., the individual most involved in care, does not have to live with patient)
  • Able to speak and understand English.

Exclusion Criteria:

\-

Study Design

Enrollment

170 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: SUPPORT-T Intervention Arm

Participants in the intervention arm will have a telehealth preparatory visit scheduled 1 week later (Week 2) with the Study Coordinator and will be provided with the study number to call with questions.

SUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and/or Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts).

• All participants will complete questionnaires at Week 1, Week 9, Month 6, and Month 12

no intervention: Enhanced Usual Care Control Group

  • Participants in the enhanced usual care arm will receive printed education materials from the Pulmonary Fibrosis Foundation (PFF) and the nurse interventionist's contact information.
  • All participants will complete questionnaires at Week 1, Week 9, Month 6, and Month 12

Interventions

SUPPORT-T Educational Intervention

SUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and/or Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts)

Primary outcome measure

  • Feasibility of Disease Preparedness [ Time Frame: 10 months ]
  • Disease Preparedness Feasibility [ Time Frame: 10 months ]

Central Contacts and Locations

Central contacts

Kathleen Lindell, PhD, RN, ATSF, FAAN

(843) 792-9763lindellk@musc.edu

Locations

Medical University of South Carolina

Recruiting

Charleston, South Carolina, United States, 29425

Contacts

Mary Chris Pittman, BA

8432594689pittmama@musc.edu

Kathleen Lindell, PhD, RN, ATSF, FAAN

(843) 792-9763lindellk@musc.edu

Principal Investigator:

Kathleen Lindell, PhD, RN, ATSF, FAAN

More Information

Sponsor

Medical University of South Carolina

Last update posted

Feb 2, 2026

Last verified

Aug, 2025

Keywords

  • Education
  • Interstitial Lung Disease (ILD)

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Medical University of South Carolina on 2026-02-02.